Loratadine: Difference between revisions
No edit summary |
|||
| Line 17: | Line 17: | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
===[[Allergic rhinitis]]=== | ===[[Allergic rhinitis]]=== | ||
*Children aged | *Children aged ≥6 years old | ||
**10 mg PO once daily, OR | **10 mg PO once daily, OR | ||
*Children aged 2 to 5 | *Children aged 2 to 5 | ||
| Line 25: | Line 25: | ||
===[[Urticaria]]=== | ===[[Urticaria]]=== | ||
*Children aged | *Children aged ≥6 years old | ||
**10 mg PO once daily | **10 mg PO once daily | ||
***Some patients may benefit from higher doses. Clinicians should weigh the risks against the benefits. | ***Some patients may benefit from higher doses. Clinicians should weigh the risks against the benefits. | ||
Revision as of 21:34, 20 May 2026
Administration
- Type: H1 antagonists (second generation)
- Dosage Forms: Tablets (chewable or orally disintegrating tablets [ODTs]), liquid-filled capsules, or a syrup (1 mg/mL solution)
- Routes of Administration: Oral
- Common Trade Names: Claritin
Adult Dosing
Allergic rhinitis
- 10 mg PO once daily, OR
- 5 mg twice daily
- Do not exceed 10 mg in 24 hours
Urticaria
- 10 mg PO once daily
- Some patients may benefit from higher doses. Clinicians should weigh the risks against the benefits.
Pediatric Dosing
Allergic rhinitis
- Children aged ≥6 years old
- 10 mg PO once daily, OR
- Children aged 2 to 5
- 5 mg PO once daily
- Do not exceed 10 mg in 24 hours
- The ODT formulation is not recommended for younger children.
Urticaria
- Children aged ≥6 years old
- 10 mg PO once daily
- Some patients may benefit from higher doses. Clinicians should weigh the risks against the benefits.
- 10 mg PO once daily
Special Populations
Pregnancy Rating
Lactation risk
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion: